ID: ALA3120791

Max Phase: Preclinical

Molecular Formula: C26H29N6O9P

Molecular Weight: 600.53

Molecule Type: Small molecule

Representations

Canonical SMILES:  CC(C)OC(=O)[C@H](C)NP(=O)(OC[C@H]1O[C@@](C#N)(c2ccc3c(N)ncnn23)[C@]2(C)OC(=O)O[C@H]12)Oc1ccccc1

Standard InChI:  InChI=1S/C26H29N6O9P/c1-15(2)37-23(33)16(3)31-42(35,41-17-8-6-5-7-9-17)36-12-19-21-25(4,40-24(34)38-21)26(13-27,39-19)20-11-10-18-22(28)29-14-30-32(18)20/h5-11,14-16,19,21H,12H2,1-4H3,(H,31,35)(H2,28,29,30)/t16-,19+,21+,25+,26-,42?/m0/s1

Standard InChI Key:  CHCXVDCTUGUOEQ-XSTQBLEDSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 600.53

Molecular Weight (Monoisotopic): 600.1734

AlogP: 2.86

#Rotatable Bonds: 10

Polar Surface Area: 198.62

Molecular Species: NEUTRAL

HBA: 14

HBD: 2

#RO5 Violations: 2

HBA (Lipinski): 15

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 2

CX Acidic pKa: 10.24

CX Basic pKa: 0.65

CX LogP: 2.51

CX LogD: 2.51

Aromatic Rings: 3

Heavy Atoms: 42

QED Weighted: 0.25

Np Likeness Score: 0.04

References

1. Cho A, Zhang L, Xu J, Lee R, Butler T, Metobo S, Aktoudianakis V, Lew W, Ye H, Clarke M, Doerffler E, Byun D, Wang T, Babusis D, Carey AC, German P, Sauer D, Zhong W, Rossi S, Fenaux M, McHutchison JG, Perry J, Feng J, Ray AS, Kim CU..  (2014)  Discovery of the first C-nucleoside HCV polymerase inhibitor (GS-6620) with demonstrated antiviral response in HCV infected patients.,  57  (5): [PMID:23547794] [10.1021/jm400201a]

Source

Source(1):

• Scientific Literature